Managing the Nutritional Needs of Older Filipino With Due Attention to Protein Nutrition and Functional Health Study
ManoPo
1 other identifier
interventional
68
1 country
1
Brief Summary
The study aims to determine the effect of protein nutrition and exercise on the body composition and functional capacity of Filipino older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2023
CompletedFirst Posted
Study publicly available on registry
July 19, 2023
CompletedStudy Start
First participant enrolled
September 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedMarch 11, 2025
March 1, 2025
1.1 years
July 12, 2023
March 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in muscle mass, as measured by dual-energy x-ray absorptiometry (DXA)
Measurement of appendicular skeletal muscle mass index (ASMI) by dividing total muscle mass (kg) of appendages with height in meters squared
Baseline, Midline (6 weeks), Endline (12 weeks)
Change in muscle strength, as measured by grip strength and leg strength (Jamar, MicroFET)
Handgrip strength is measured using a hydraulic hand dynamometer through maximum exertion of grip force (in kilograms). Leg strength is measured using a hand-held dynamometer. Participant will use strongest leg force to push against the resistance brought upon by the researcher while holding the measuring device.
Baseline, Midline (6 weeks), Endline (12 weeks)
Change in physical performance, as measured by timed up-and-go test
Faster time duration to complete the test indicate lesser risk for falls
Baseline, Midline (6 weeks), Endline (12 weeks)
Change in physical performance, as measured by short physical performance battery
Score ranges from 0 to 12 with a higher score indicating better functionality
Baseline, Midline (6 weeks), Endline (12 weeks)
Change in physical performance, as measured by 10-meter walk test
Faster walking speed (in meters per second) indicate better functionality
Baseline, Midline (6 weeks), Endline (12 weeks)
Study Arms (2)
Intervention Group
ACTIVE COMPARATORA protein product (combination of whey protein and plant-derived protein) in powdered form with flavoring. Product will be added to 180-200 mL of warm water prior to consumption.
Placebo Group
PLACEBO COMPARATORAn isocaloric product (made with maltodextrin) in powdered form with flavoring. Product will be added to 180-200 mL of warm water prior to consumption.
Interventions
Blinded researchers will provide the randomly assigned supplement product to the trial participants for a period of 90 days. Used packaging will be collected at the end of every week from each trial participant to monitor compliance.
Trained researchers will facilitate resistance-based exercises two to three times a week in an enclosed venue (gym). Trial participants will be assessed at baseline for one repetition maximum (1RM) which will serve as a basis for load progression. A target of 3 sets and 6-15 repetitions with at least 30 seconds rest in between sets will be performed by the trial participants under supervision of a trained researcher.
Eligibility Criteria
You may qualify if:
- Pre-sarcopenia/pre-frail
- Aged 60 years old and above, male or female
- Free-living in the community, ambulatory
- Able to respond to food recall/interview as self-declared
- Normal cardiac function as measured by resting ECG
You may not qualify if:
- Bed ridden, unable to perform exercise independently
- Presence of serious medical condition (i.e. cancer, existing fracture)
- Presence of unmanaged hypertension and/or type 2 diabetes or upon assessment of physician
- Renal Problem
- Under controlled or medically-supervised diet not flexible to include the intervention agent
- Allergic to any ingredients in the nutrition supplementation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Science and Technology-Food and Nutrition Research Institute
City of Taguig, National Capital Region, 1631, Philippines
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robby Carlo A Tan, Msc
Department of Science and Technology-Food and Nutrition Research Institute (DOST-FNRI)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- The trial participants and researchers will be blinded during the conduct of the 12-week intervention. An independent third party will handle randomization and allocation of participants to either intervention group (DOST-FNRI protein drink + physical activity) or placebo group (placebo product + physical activity), while trying to ensure a balanced sex distribution between the groups. The intervention group will receive a protein-containing product which shall meet the target of 30g of protein per day of supplementation. Meanwhile, the placebo group will receive an isocaloric product (similar caloric value but with minimal to no protein content). Both products will have similar packaging, appearance, taste, and flavoring. A unique serial number only known by the independent third party will be used to differentiate between the two products. Unblinding of trial participants will be done after data analysis of a locked dataset.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Science Research Specialist
Study Record Dates
First Submitted
July 12, 2023
First Posted
July 19, 2023
Study Start
September 4, 2023
Primary Completion
September 30, 2024
Study Completion
September 30, 2024
Last Updated
March 11, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share